The Compound U18666A Inhibits the Intoxication of Cells by Clostridioides difficile Toxins TcdA and TcdB

The intestinal pathogen Clostridioides (C.) difficile is a major cause of diarrhea both in hospitals and outpatient in industrialized countries. This bacterium produces two large exotoxins, toxin A (TcdA) and toxin B (TcdB), which are directly responsible for the onset of clinical symptoms of C. dif...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Panagiotis Papatheodorou, Selina Kindig, Adriana Badilla-Lobo, Stephan Fischer, Ebru Durgun, Tharani Thuraisingam, Alexander Witte, Shuo Song, Klaus Aktories, Esteban Chaves-Olarte, César Rodríguez, Holger Barth
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/0c5e3af2c59d40f5bf76f1817af04c77
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0c5e3af2c59d40f5bf76f1817af04c77
record_format dspace
spelling oai:doaj.org-article:0c5e3af2c59d40f5bf76f1817af04c772021-12-01T13:49:43ZThe Compound U18666A Inhibits the Intoxication of Cells by Clostridioides difficile Toxins TcdA and TcdB1664-302X10.3389/fmicb.2021.784856https://doaj.org/article/0c5e3af2c59d40f5bf76f1817af04c772021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fmicb.2021.784856/fullhttps://doaj.org/toc/1664-302XThe intestinal pathogen Clostridioides (C.) difficile is a major cause of diarrhea both in hospitals and outpatient in industrialized countries. This bacterium produces two large exotoxins, toxin A (TcdA) and toxin B (TcdB), which are directly responsible for the onset of clinical symptoms of C. difficile-associated diseases (CDADs), such as antibiotics-associated diarrhea and the severe, life-threatening pseudomembranous colitis. Both toxins are multidomain proteins and taken up into host eukaryotic cells via receptor-mediated endocytosis. Within the cell, TcdA and TcdB inactivate Rho and/or Ras protein family members by glucosylation, which eventually results in cell death. The cytotoxic mode of action of the toxins is the main reason for the disease. Thus, compounds capable of inhibiting the cellular uptake and/or mode-of-action of both toxins are of high therapeutic interest. Recently, we found that the sterol regulatory element-binding protein 2 (SREBP-2) pathway, which regulates cholesterol content in membranes, is crucial for the intoxication of cells by TcdA and TcdB. Furthermore, it has been shown that membrane cholesterol is required for TcdA- as well as TcdB-mediated pore formation in endosomal membranes, which is a key step during the translocation of the glucosyltransferase domain of both toxins from endocytic vesicles into the cytosol of host cells. In the current study, we demonstrate that intoxication by TcdA and TcdB is diminished in cultured cells preincubated with the compound U18666A, an established inhibitor of cholesterol biosynthesis and/or intracellular transport. U18666A-pretreated cells were also less sensitive against TcdA and TcdB variants from the epidemic NAP1/027 C. difficile strain. Our study corroborates the crucial role of membrane cholesterol for cell entry of TcdA and TcdB, thus providing a valuable basis for the development of novel antitoxin strategies in the context of CDADs.Panagiotis PapatheodorouSelina KindigAdriana Badilla-LoboStephan FischerEbru DurgunTharani ThuraisingamAlexander WitteShuo SongKlaus AktoriesEsteban Chaves-OlarteCésar RodríguezHolger BarthFrontiers Media S.A.articlebacterial toxintoxin inhibitorcholesterol biosynthesischolesterol transportcholesterolMicrobiologyQR1-502ENFrontiers in Microbiology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic bacterial toxin
toxin inhibitor
cholesterol biosynthesis
cholesterol transport
cholesterol
Microbiology
QR1-502
spellingShingle bacterial toxin
toxin inhibitor
cholesterol biosynthesis
cholesterol transport
cholesterol
Microbiology
QR1-502
Panagiotis Papatheodorou
Selina Kindig
Adriana Badilla-Lobo
Stephan Fischer
Ebru Durgun
Tharani Thuraisingam
Alexander Witte
Shuo Song
Klaus Aktories
Esteban Chaves-Olarte
César Rodríguez
Holger Barth
The Compound U18666A Inhibits the Intoxication of Cells by Clostridioides difficile Toxins TcdA and TcdB
description The intestinal pathogen Clostridioides (C.) difficile is a major cause of diarrhea both in hospitals and outpatient in industrialized countries. This bacterium produces two large exotoxins, toxin A (TcdA) and toxin B (TcdB), which are directly responsible for the onset of clinical symptoms of C. difficile-associated diseases (CDADs), such as antibiotics-associated diarrhea and the severe, life-threatening pseudomembranous colitis. Both toxins are multidomain proteins and taken up into host eukaryotic cells via receptor-mediated endocytosis. Within the cell, TcdA and TcdB inactivate Rho and/or Ras protein family members by glucosylation, which eventually results in cell death. The cytotoxic mode of action of the toxins is the main reason for the disease. Thus, compounds capable of inhibiting the cellular uptake and/or mode-of-action of both toxins are of high therapeutic interest. Recently, we found that the sterol regulatory element-binding protein 2 (SREBP-2) pathway, which regulates cholesterol content in membranes, is crucial for the intoxication of cells by TcdA and TcdB. Furthermore, it has been shown that membrane cholesterol is required for TcdA- as well as TcdB-mediated pore formation in endosomal membranes, which is a key step during the translocation of the glucosyltransferase domain of both toxins from endocytic vesicles into the cytosol of host cells. In the current study, we demonstrate that intoxication by TcdA and TcdB is diminished in cultured cells preincubated with the compound U18666A, an established inhibitor of cholesterol biosynthesis and/or intracellular transport. U18666A-pretreated cells were also less sensitive against TcdA and TcdB variants from the epidemic NAP1/027 C. difficile strain. Our study corroborates the crucial role of membrane cholesterol for cell entry of TcdA and TcdB, thus providing a valuable basis for the development of novel antitoxin strategies in the context of CDADs.
format article
author Panagiotis Papatheodorou
Selina Kindig
Adriana Badilla-Lobo
Stephan Fischer
Ebru Durgun
Tharani Thuraisingam
Alexander Witte
Shuo Song
Klaus Aktories
Esteban Chaves-Olarte
César Rodríguez
Holger Barth
author_facet Panagiotis Papatheodorou
Selina Kindig
Adriana Badilla-Lobo
Stephan Fischer
Ebru Durgun
Tharani Thuraisingam
Alexander Witte
Shuo Song
Klaus Aktories
Esteban Chaves-Olarte
César Rodríguez
Holger Barth
author_sort Panagiotis Papatheodorou
title The Compound U18666A Inhibits the Intoxication of Cells by Clostridioides difficile Toxins TcdA and TcdB
title_short The Compound U18666A Inhibits the Intoxication of Cells by Clostridioides difficile Toxins TcdA and TcdB
title_full The Compound U18666A Inhibits the Intoxication of Cells by Clostridioides difficile Toxins TcdA and TcdB
title_fullStr The Compound U18666A Inhibits the Intoxication of Cells by Clostridioides difficile Toxins TcdA and TcdB
title_full_unstemmed The Compound U18666A Inhibits the Intoxication of Cells by Clostridioides difficile Toxins TcdA and TcdB
title_sort compound u18666a inhibits the intoxication of cells by clostridioides difficile toxins tcda and tcdb
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/0c5e3af2c59d40f5bf76f1817af04c77
work_keys_str_mv AT panagiotispapatheodorou thecompoundu18666ainhibitstheintoxicationofcellsbyclostridioidesdifficiletoxinstcdaandtcdb
AT selinakindig thecompoundu18666ainhibitstheintoxicationofcellsbyclostridioidesdifficiletoxinstcdaandtcdb
AT adrianabadillalobo thecompoundu18666ainhibitstheintoxicationofcellsbyclostridioidesdifficiletoxinstcdaandtcdb
AT stephanfischer thecompoundu18666ainhibitstheintoxicationofcellsbyclostridioidesdifficiletoxinstcdaandtcdb
AT ebrudurgun thecompoundu18666ainhibitstheintoxicationofcellsbyclostridioidesdifficiletoxinstcdaandtcdb
AT tharanithuraisingam thecompoundu18666ainhibitstheintoxicationofcellsbyclostridioidesdifficiletoxinstcdaandtcdb
AT alexanderwitte thecompoundu18666ainhibitstheintoxicationofcellsbyclostridioidesdifficiletoxinstcdaandtcdb
AT shuosong thecompoundu18666ainhibitstheintoxicationofcellsbyclostridioidesdifficiletoxinstcdaandtcdb
AT klausaktories thecompoundu18666ainhibitstheintoxicationofcellsbyclostridioidesdifficiletoxinstcdaandtcdb
AT estebanchavesolarte thecompoundu18666ainhibitstheintoxicationofcellsbyclostridioidesdifficiletoxinstcdaandtcdb
AT cesarrodriguez thecompoundu18666ainhibitstheintoxicationofcellsbyclostridioidesdifficiletoxinstcdaandtcdb
AT holgerbarth thecompoundu18666ainhibitstheintoxicationofcellsbyclostridioidesdifficiletoxinstcdaandtcdb
AT panagiotispapatheodorou compoundu18666ainhibitstheintoxicationofcellsbyclostridioidesdifficiletoxinstcdaandtcdb
AT selinakindig compoundu18666ainhibitstheintoxicationofcellsbyclostridioidesdifficiletoxinstcdaandtcdb
AT adrianabadillalobo compoundu18666ainhibitstheintoxicationofcellsbyclostridioidesdifficiletoxinstcdaandtcdb
AT stephanfischer compoundu18666ainhibitstheintoxicationofcellsbyclostridioidesdifficiletoxinstcdaandtcdb
AT ebrudurgun compoundu18666ainhibitstheintoxicationofcellsbyclostridioidesdifficiletoxinstcdaandtcdb
AT tharanithuraisingam compoundu18666ainhibitstheintoxicationofcellsbyclostridioidesdifficiletoxinstcdaandtcdb
AT alexanderwitte compoundu18666ainhibitstheintoxicationofcellsbyclostridioidesdifficiletoxinstcdaandtcdb
AT shuosong compoundu18666ainhibitstheintoxicationofcellsbyclostridioidesdifficiletoxinstcdaandtcdb
AT klausaktories compoundu18666ainhibitstheintoxicationofcellsbyclostridioidesdifficiletoxinstcdaandtcdb
AT estebanchavesolarte compoundu18666ainhibitstheintoxicationofcellsbyclostridioidesdifficiletoxinstcdaandtcdb
AT cesarrodriguez compoundu18666ainhibitstheintoxicationofcellsbyclostridioidesdifficiletoxinstcdaandtcdb
AT holgerbarth compoundu18666ainhibitstheintoxicationofcellsbyclostridioidesdifficiletoxinstcdaandtcdb
_version_ 1718405100458737664